LexisNexis(TM) Academic - Document
Copyright 2005 The Financial Times Limited
Financial Times (London, England)
August 30, 2005 Tuesday
London Edition 1
SECTION: COMPANIES ASIA-PACIFIC; Pg. 22
LENGTH: 749 words
HEADLINE: Wall Street learns tricks of the China trade Investment banks have discovered that to win advisory mandates in China, strong ties are no longer enough, says Francesco Guerrera
BYLINE: By FRANCESCO GUERRERA
BODY:
At the beginning of the year, a high-powered team from a Wall Street bank flew into China to look into investing in two of the country's four largest lenders - Industrial and Commercial Bank of China and Bank of China.
After a week of meetings, as the leader of this taskforce was preparing to leave Beijing, his phone rang.
To his surprise, at the other end of the line was an official from China Construction Bank - another "Big Four" state lender and an arch-rival of ICBC and BoC - asking the foreign investment bank to consider a potential investment.
Such unashamed desire by China's troubled financial groups, and their political masters, to attract funds and expertise from foreign rivals ahead of overseas listings is forcing investment banks to overhaul their approach to the country.
After China began to privatise its industries, "bulge bracket" institutions quickly learnt that to win lucrative and prestigious equity mandates they had to start early. By getting close to the top company executives and by hosting banquets for the right government officials in the years before the deal, they were able to show the commitment needed to win coveted initial public offerings.
One veteran China banker says IPOs "were never won in the months before the deal, they were won and lost in the years beforehand".
Stake purchases were left to strategic investors such as the global oil majors that spent billions of dollars to buy into their Chinese rivals - PetroChina, CNOOC and Sinopec - ahead of their IPOs.
But recent multi-million dollar acquisitions of equity holdings by investment banks appear to suggest that in China, a capital injection can be as valuable as first-mover advantage. This month, Merrill Lynch took part in a Dollars 3.1bn consortium headed by Royal Bank of Scotland that bought a 10 per cent stake in BoC.
UBS is also believed to be close to buying a stake of some Dollars 500m in the lender, while Credit Suisse is considering a similar-sized investment in CCB. Goldman Sachs, together with German insurer Allianz, wants to buy a holding worth as much as Dollars 2bn in ICBC.
All banks strenuously deny any link between such purchases and equity mandates, arguing that they must judge the investments on their merits because IPO fees are much lower than the amounts spent on the holdings. Yet, the unwritten rule is that putting up capital strengthens a bank's case for IPO work.
HSBC, which invested Dollars 1.7bn in Bank of Communications and another Dollars 600m in insurer Ping An ahead of their IPOs, was duly selected as a lead adviser on both listings. Conversely, in June Citigroup was ousted from CCB's Dollars 5bn IPO amid accusations it had gone back on a pledge to buy a stake.
Analysts argue that the financial sector is in a unique position in the drive to privatisation because investment banks are seen as both advisers and strategic investors.
But Chinese banks' hunger for foreign help to rectify the financial and managerial mistakes of decades of government-directed policies is adding to the competitive pressures.
Goldman Sachs' interest in ICBC, for example, threatens to derail CSFB's long-standing plan to advise China's largest bank, and could be behind the Swiss group's move to lobby aggressively for a role in CCB's listing.
For its part, Goldman Sachs saw its strong links with BoC threatened by Merrill Lynch's investment until last week, when it won the mandate for the Chinese bank's listing.
But the crucial issue for Wall Street firms and their shareholders is whether investing in Chinese banks makes financial sense, regardless of the mandates.
With strategic investors such as RBS in BoC, and Bank of America in CCB having priority on joint ventures in areas such as credit cards and mortgages, investment banks may be left with little more than private equity positions.
Goldman Sachs made that clear by charging its venture capital arm with the ICBC talks. Others, such as Merrill Lynch and CSFB, privately concede their main hope is to sell their Chinese stakes at a profit in years to come.
That may be a lucrative tactic, given the heady rises seen in overseas-listed Chinese stocks. But it also raises Wall Street's stakes, and risks, in China.
As a senior executive from an investment bank that has not bought into a Chinese "Big Four" lender says: "It is fine to say these are private equity investments, but can they achieve private equity returns (of 20-30 per cent of the original sum) or would the capital be better deployed elsewhere?"
LOAD-DATE: August 29, 2005
Financial Times (London, England)
August 30, 2005 Tuesday
London Edition 1
SECTION: COMPANIES ASIA-PACIFIC; Pg. 22
LENGTH: 749 words
HEADLINE: Wall Street learns tricks of the China trade Investment banks have discovered that to win advisory mandates in China, strong ties are no longer enough, says Francesco Guerrera
BYLINE: By FRANCESCO GUERRERA
BODY:
At the beginning of the year, a high-powered team from a Wall Street bank flew into China to look into investing in two of the country's four largest lenders - Industrial and Commercial Bank of China and Bank of China.
After a week of meetings, as the leader of this taskforce was preparing to leave Beijing, his phone rang.
To his surprise, at the other end of the line was an official from China Construction Bank - another "Big Four" state lender and an arch-rival of ICBC and BoC - asking the foreign investment bank to consider a potential investment.
Such unashamed desire by China's troubled financial groups, and their political masters, to attract funds and expertise from foreign rivals ahead of overseas listings is forcing investment banks to overhaul their approach to the country.
After China began to privatise its industries, "bulge bracket" institutions quickly learnt that to win lucrative and prestigious equity mandates they had to start early. By getting close to the top company executives and by hosting banquets for the right government officials in the years before the deal, they were able to show the commitment needed to win coveted initial public offerings.
One veteran China banker says IPOs "were never won in the months before the deal, they were won and lost in the years beforehand".
Stake purchases were left to strategic investors such as the global oil majors that spent billions of dollars to buy into their Chinese rivals - PetroChina, CNOOC and Sinopec - ahead of their IPOs.
But recent multi-million dollar acquisitions of equity holdings by investment banks appear to suggest that in China, a capital injection can be as valuable as first-mover advantage. This month, Merrill Lynch took part in a Dollars 3.1bn consortium headed by Royal Bank of Scotland that bought a 10 per cent stake in BoC.
UBS is also believed to be close to buying a stake of some Dollars 500m in the lender, while Credit Suisse is considering a similar-sized investment in CCB. Goldman Sachs, together with German insurer Allianz, wants to buy a holding worth as much as Dollars 2bn in ICBC.
All banks strenuously deny any link between such purchases and equity mandates, arguing that they must judge the investments on their merits because IPO fees are much lower than the amounts spent on the holdings. Yet, the unwritten rule is that putting up capital strengthens a bank's case for IPO work.
HSBC, which invested Dollars 1.7bn in Bank of Communications and another Dollars 600m in insurer Ping An ahead of their IPOs, was duly selected as a lead adviser on both listings. Conversely, in June Citigroup was ousted from CCB's Dollars 5bn IPO amid accusations it had gone back on a pledge to buy a stake.
Analysts argue that the financial sector is in a unique position in the drive to privatisation because investment banks are seen as both advisers and strategic investors.
But Chinese banks' hunger for foreign help to rectify the financial and managerial mistakes of decades of government-directed policies is adding to the competitive pressures.
Goldman Sachs' interest in ICBC, for example, threatens to derail CSFB's long-standing plan to advise China's largest bank, and could be behind the Swiss group's move to lobby aggressively for a role in CCB's listing.
For its part, Goldman Sachs saw its strong links with BoC threatened by Merrill Lynch's investment until last week, when it won the mandate for the Chinese bank's listing.
But the crucial issue for Wall Street firms and their shareholders is whether investing in Chinese banks makes financial sense, regardless of the mandates.
With strategic investors such as RBS in BoC, and Bank of America in CCB having priority on joint ventures in areas such as credit cards and mortgages, investment banks may be left with little more than private equity positions.
Goldman Sachs made that clear by charging its venture capital arm with the ICBC talks. Others, such as Merrill Lynch and CSFB, privately concede their main hope is to sell their Chinese stakes at a profit in years to come.
That may be a lucrative tactic, given the heady rises seen in overseas-listed Chinese stocks. But it also raises Wall Street's stakes, and risks, in China.
As a senior executive from an investment bank that has not bought into a Chinese "Big Four" lender says: "It is fine to say these are private equity investments, but can they achieve private equity returns (of 20-30 per cent of the original sum) or would the capital be better deployed elsewhere?"
LOAD-DATE: August 29, 2005
